- Johnson & Johnson

Company:

Johnson & Johnson

Current Parent Company:

Johnson & Johnson

Penalty:

$541,000,000

Year:

2013

Date:

November 4, 2013

Offense Group:

healthcare-related offenses

Primary Offense:

off-label or unapproved promotion of medical products

Secondary Offense:

kickbacks and bribery

Violation Description:

Johnson & Johnson and its subsidiaries agreed to pay $541 million to resolve multistate litigation alleging unlawful marketing practices, including off-label promotion and kickbacks, to promote the sales of their atypical antipsychotic drugs, Risperdal and Invega. The off-label marketing accounted for $524 million; the other $17 million resolved allegations that J&J subsidiary Janssen paid kickbacks to nuring home pharmacy Omnicare. All of this was part of a larger $2.2 billion civil and criminal settlement involving the federal government; see the Violation Tracker entry at https://violationtracker.goodjobsfirst.org/violation-tracker/-johnson-and-johnson

Level of Government:

state

Action Type:

agency action

Agency:

Multistate Attorneys General Case

Civil or Criminal Case:

civil

HQ Country of Parent:

USA

HQ State of Parent:

New Jersey

Ownership Structure of Parent:

publicly traded

Major Industry of Parent:

pharmaceuticals

Specific Industry of Parent:

pharmaceuticals

Source of Data:

https://www.justice.gov/opa/pr/johnson-johnson-pay-more-22-billion-resolve-criminal-and-civil-investigations

Source Notes:

If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.

Parent company note:

Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.

- Johnson & Johnson

Violation Tracker Individual Record